日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Patients With Nonfast Peritoneal Transfer Rate are More Suitable for Incremental Peritoneal Dialysis

腹膜透析速率不快的患者更适合进行递增式腹膜透析。

Guo, Jing; Xin, Yangyang; Zhou, Ting; Tu, Shiyan; Mo, Xilong; Wu, Haishan; Yi, Chunyan; Lin, Jianxiong; Ye, Hongjian; Yang, Xiao

Oroxylin A may promote cell apoptosis and inhibit epithelial-mesenchymal transition in endometrial cancer, associated with the ERβ/PI3K/AKT pathway.

木犀草素 A 可能促进子宫内膜癌细胞凋亡并抑制上皮间质转化,这与 ERβ/PI3K/AKT 通路有关

Fan Xue, Wu Luming, Cheng Tong, Lv Weilong, Tian Jiao, Tao Jijun, Tu Shiyan, Tan Fangjun, Wang Yiqing

Association Between Atherogenic Index of Plasma and Clinical Outcomes in Peritoneal Dialysis Population

血浆动脉粥样硬化指数与腹膜透析患者临床结局的相关性

Lan, Jiayao; Yi, Chunyan; Liu, Ruihua; Guo, Jing; Tu, Shiyan; Wu, Haishan; Lin, Jianxiong; Mao, Haiping; Ye, Hongjian; Chen, Wei; Yang, Xiao

Early Anuria in Incident Peritoneal Dialysis Patients: Incidence, Risk Factors, and Associated Clinical Outcomes

新发腹膜透析患者早期无尿:发生率、危险因素及相关临床结局

Tu, Shiyan; Ye, Hongjian; Xin, Yangyang; Peng, Yuan; Liu, Ruihua; Guo, Jing; Yi, Chunyan; Mao, Haiping; Yang, Xiao

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Anti-C5a Antibody BDB-001 for Severe COVID-19: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Clinical Trial in Healthy Chinese Adults

抗C5a抗体BDB-001治疗重症COVID-19的安全性、耐受性、药代动力学和药效学:一项在中国健康成年人中进行的随机、双盲、安慰剂对照的1期临床试验

Chen, Guiling; Li, Nan; Dai, Xiahong; Tu, Shiyan; Shen, Zhenwei; Wu, Kaiqi; Jin, Tinghan; Wu, Jiajun; Peng, Conggao; Sheng, Guoping; Zhu, Mengfei; Tang, Lingling; Li, Lanjuan

Clinical outcomes of patients with hepatic insufficiency undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis

肝功能不全患者经导管主动脉瓣置换术的临床结果:系统评价和荟萃分析

Jiang, Wenkai; Cheng, Zeyi; Tu, Shiyan; Wang, Xing; Xiang, Caifei; Zhou, Wence; Chen, Lin